Drug intelligence / Profile preview

metformin + scaling and root planing

Development stage
Unknown
Lead developer
Government Dental College and Research Institute
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Metformin 1% gel is an investigational local drug delivery system used as an adjunct to scaling and root planing (SRP) for the treatment of periodontal defects, specifically Class II furcation defects, in patients with chronic periodontitis. Developed by researchers at the Government Dental College and Research Institute in Bangalore, this biodegradable gel formulation is designed for subgingival application to provide controlled release of the active ingredient. Metformin, a biguanide small molecule traditionally used for type 2 diabetes, is utilized in this context for its pleiotropic bone-sparing properties. It acts by stimulating osteoblast differentiation and inhibiting osteoclastogenesis, thereby promoting alveolar bone regeneration and the repair of intrabony defects when delivered locally to the site of infection.

Other names
1% metformin gelmetformin gelMF gelSRP + metformin
02

Targets

ND1 (Mitochondrial electron transport chain complex I)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on metformin + scaling and root planing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metformin + scaling and root planing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call